AIkido Pharma names new president of Dominari Financial
22 July 2022 -

AIkido Pharma Inc. (NASDAQ: AIKI), a US-based biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics, announced on Thursday that it has named Carlos Aldavero as the new president of Dominari Financial, Aikido's recently formed financial services subsidiary.

In the new role, Aldavero will be responsible for identifying strategic assets in the fintech and financial services sector for acquisition and investment, while creating an organisational structure that uses the inherent synergies of an accretive business model.

Aldavero has served as associate complex manager at Morgan Stanley. He has held management positions at companies including Merrill Lynch, Pierce, Fenner & Smith Inc., Copernicus Institutional Advisors LLC, and Deutsche Bank, among others.